After resuming pre-market trading, shares of Aldeyra (ALDX) are down $4.00, or 75%, to $1.32.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALDX:
- Aldeyra receives Complete Response Letter from FDA for Reproxalap NDA
- Aldeyra receives complete response letter from FDA for reproxalap NDA
- Aldeyra options imply 29.5% move in share price post-earnings
- Aldeyra options imply 30.8% move in share price post-earnings
- Aldeyra Therapeutics: Buy Rating Affirmed on Promising Reproxalap and Strategic RASP Market Expansion